Page last updated: 2024-09-05

vx-745 and quinazolines

vx-745 has been researched along with quinazolines in 3 studies

Compound Research Comparison

Studies
(vx-745)
Trials
(vx-745)
Recent Studies (post-2010)
(vx-745)
Studies
(quinazolines)
Trials
(quinazolines)
Recent Studies (post-2010) (quinazolines)
5813519,2352,4178,835

Protein Interaction Comparison

ProteinTaxonomyvx-745 (IC50)quinazolines (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.027

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becker, JW; Cameron, PM; Fitzgerald, CE; O'Keefe, SJ; Patel, SB; Pikounis, VB; Scapin, G; Zaller, D1
Laufer, S; Wagner, G1
Natarajan, SR; O'Keefe, SJ; O'Neill, EA; Thompson, JE; Wisnoski, DD1

Reviews

1 review(s) available for vx-745 and quinazolines

ArticleYear
Small molecular anti-cytokine agents.
    Medicinal research reviews, 2006, Volume: 26, Issue:1

    Topics: ADAM Proteins; ADAM17 Protein; Animals; Caspase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytokines; Humans; Hydroxamic Acids; Imidazoles; Matrix Metalloproteinase Inhibitors; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridazines; Pyridines; Pyrimidines; Quinazolines; Structure-Activity Relationship; Succinates; Thiazoles; Tumor Necrosis Factor-alpha; Urea

2006

Other Studies

2 other study(ies) available for vx-745 and quinazolines

ArticleYear
Structural basis for p38alpha MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity.
    Nature structural biology, 2003, Volume: 10, Issue:9

    Topics: Amino Acid Sequence; Animals; Cloning, Molecular; Enzyme Inhibitors; Glycine; Imidazoles; Inhibitory Concentration 50; Kinetics; Mice; Mitogen-Activated Protein Kinase 14; Mitogen-Activated Protein Kinases; Models, Chemical; Models, Molecular; Molecular Sequence Data; Mutation; Peptides; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; Pyridazines; Pyridines; Pyrimidines; Quinazolines; Sequence Homology, Amino Acid

2003
p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-d]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-d]pyrimidin-2-ones.
    Bioorganic & medicinal chemistry letters, 2006, Aug-15, Volume: 16, Issue:16

    Topics: Chemistry, Pharmaceutical; Drug Design; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Models, Chemical; p38 Mitogen-Activated Protein Kinases; Pyridazines; Pyridines; Pyrimidines; Pyrimidinones; Quinazolines; Structure-Activity Relationship

2006